Faiz Ahmad Mohammed
Director Eli Lilly & Co.
Seminars
Discovery and analytical scientists often use similar biophysical tools, but at different stages and for different goals. This workshop brings both groups together to identify how analytical insights can be applied earlier in discovery, and how discovery-stage decisions can better prepare molecules for downstream development.
This session will cover how cutting-edge biophysical tools and strategies can accelerate molecule characterization, inform developability from aggregation to solubility, and stability, to enhance collaboration across discovery and development teams.
Join your peers to collectively discuss:
- Aligning discovery and analytical objectives when using biophysical data to assess stability, aggregation, and solubility
- Mapping where biophysical data from discovery (e.g., binding, conformation, solubility) can feed into analytical development pipelines
- How analytical parameters like viscosity, aggregation propensity, and high concentration stability can inform molecule engineering before handover
- Examples of organizations integrating analytical scientists into discovery teams, exploring what’s working and what still needs solving
- Emerging techniques (mass photometry, micro-ED, nanoDSF) that are closing the gap between early discovery and formulation insight.
Why Take Part?
Leave with a set of actionable strategies to build cross-functional workflows, accelerate candidate assessment, and use biophysical data to design molecules that are both effective and developable.